Itama Ranoraya Pemeriksaan Rutin Bantu Deteksi Dini Potensi Kanker Payudara - Pressrelease.id
| IRRA Stock | IDR 418.00 2.00 0.48% |
About 62% of Itama Ranoraya's investor base is looking to short. The analysis of current outlook of investing in Itama Ranoraya suggests that many traders are alarmed regarding Itama Ranoraya's prospects. Itama Ranoraya's investing sentiment shows overall attitude of investors towards Itama Ranoraya.
Itama |
Itama Ranoraya Pemeriksaan Rutin Bantu Deteksi Dini Potensi Kanker Payudara Pressrelease.id
Read at news.google.com
 |
Itama Ranoraya Fundamental Analysis
We analyze Itama Ranoraya's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Itama Ranoraya using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Itama Ranoraya based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Itama Ranoraya is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Itama Ranoraya Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Itama Ranoraya stock to make a market-neutral strategy. Peer analysis of Itama Ranoraya could also be used in its relative valuation, which is a method of valuing Itama Ranoraya by comparing valuation metrics with similar companies.
Peers
Itama Ranoraya Related Equities
| BRIS | Bank BRISyariah | 0.34 | ||||
| INAF | Indofarma Tbk | 0.00 | ||||
| AGRO | Bank Rakyat | 0.83 | ||||
| MDKA | Merdeka Copper | 1.01 | ||||
| KAEF | Kimia Farma | 3.03 |
Other Information on Investing in Itama Stock
Itama Ranoraya financial ratios help investors to determine whether Itama Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Itama with respect to the benefits of owning Itama Ranoraya security.